The treatment of SLE: the case of conservative management.
D000305:Adrenal Cortex Hormones / Q000009:adverse effects / Q000627:therapeutic use; D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use; D000927:Anticonvulsants / Q000009:adverse effects / Q000627:therapeutic use; D000962:Antimalarials / Q000009:adverse effects / Q000627:therapeutic use; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D001323:Autoantibodies / Q000096:biosynthesis; D002493:Central Nervous System Diseases / Q000188:drug therapy / Q000209:etiology; D003165:Complement System Proteins / Q000032:analysis; D003276:Contraceptives, Oral / Q000009:adverse effects; D004247:DNA / Q000276:immunology; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D006801:Humans; D007105:Immune Complex Diseases / Q000175:diagnosis / Q000209:etiology; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D008111:Liver Function Tests; D008179:Lupus Erythematosus, Discoid / Q000188:drug therapy; D008180:Lupus Erythematosus, Systemic / Q000150:complications / Q000175:diagnosis / Q000188:drug therapy*; D051379:Mice; D010956:Plasmapheresis
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents; D000927:Anticonvulsants; D000962:Antimalarials; D001323:Autoantibodies; D003276:Contraceptives, Oral; D007166:Immunosuppressive Agents; D003165:Complement System Proteins; D004247:DNA; D001241:Aspirin